MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + Placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Osteoarthritis of Knee
Conditions
Osteoarthritis of Knee
Trial Timeline
Dec 22, 2020 → Aug 10, 2022
NCT ID
NCT04506463About MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + Placebo
MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + Placebo is a phase 2 stage product being developed by Sun Pharmaceutical for Osteoarthritis of Knee. The current trial status is completed. This product is registered under clinical trial identifier NCT04506463. Target conditions include Osteoarthritis of Knee.
What happened to similar drugs?
20 of 20 similar drugs in Osteoarthritis of Knee were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04506463 | Phase 2 | Completed |
Competing Products
20 competing products in Osteoarthritis of Knee